世界各国のリアルタイムなデータ・インテリジェンスで皆様をお手伝い

遺伝子疾患診断の世界市場規模、メーカー、サプライチェーン、販売チャネル、顧客、2022-2028年


Global Genetic Disease Diagnostic Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2022-2028

遺伝性疾患とは、遺伝子の変化により引き起こされる疾患、または疾患原因遺伝子により制御される疾患をいう。遺伝性疾患とは、遺伝的要因によって全部または一部が決定される疾患を指し、通常、先天性または後天... もっと見る

 

 

出版社 出版年月 電子版価格 言語
QYResearch
QYリサーチ
2022年10月11日 US$5,900
シングルユーザライセンス
ライセンス・価格情報
注文方法はこちら
英語

※当ページの内容はウェブ更新時の情報です。
最新版の価格やページ数などの情報についてはお問合せください。

日本語のページは自動翻訳を利用し作成しています。
実際のレポートは英文のみでご納品いたします。


 

サマリー

遺伝性疾患とは、遺伝子の変化により引き起こされる疾患、または疾患原因遺伝子により制御される疾患をいう。遺伝性疾患とは、遺伝的要因によって全部または一部が決定される疾患を指し、通常、先天性または後天性である。先天性の愚かなモデルのように、多くのポイントに(つま先)、先天性難聴ダム、血友病、これらの遺伝性疾患は、遺伝的要因によって完全に来ることを決定し、ちょうど生まれた後に特定の時間が来る、時には数年、10年以上の能力を渡すためにしたい数年後に明らかに症状が表示されます。

現在、中国は様々な新生児疾患スクリーニング技術を採用し、臨床症状のない遺伝性疾患の子供の早期診断と治療を行い、子供の障害率と死亡率を効果的に減少させ、出生欠陥が家族と社会にもたらす深刻な害を大幅に減少させています。近年、分子生物学とゲノム科学の急速な発展により、遺伝性疾患の診断のほとんどにおいて、遺伝子検査技術はゴールドスタンダードとなり、特に生化学的または酵素的な方法では診断ができず、検査結果が明確でない状況下では、遺伝子検査は重要な診断手段ですが、新生児遺伝性疾患スクリーニングの分野では、遺伝子検査技術はまだ応用が熟していない、中国では新生児聴覚障害に対する遺伝子スクリーニングが報告されました。

ハイライト
COVID-19やロシア・ウクライナ戦争の影響による経済変化を考慮すると、遺伝子疾患診断の世界市場は、2023年から2028年の間に年率%で、2022年の推定百万米ドルから2028年には百万米ドルに達すると予測されます。
中国市場では、遺伝子疾患診断の中核メーカーにはBGIグループ、Berry Genomicsなどがあり、上位5社で40%以上のシェアを占めています。

レポート対象範囲
本レポートは、読者がビジネス/成長戦略を策定し、市場の競争状況を評価し、現在の市場における自社のポジションを分析し、遺伝子疾患診断に関するビジネス上の意思決定を行うのに役立つ、遺伝子疾患診断の世界市場について定量・定性分析を交えて包括的に提示することを目的としています。

遺伝子疾患診断の市場規模、推計、予測は、2021年を基準年とし、2017年から2028年までの歴史と予測データを考慮し、収益(百万ドル)の単位で提供しています。本レポートでは、世界の遺伝性疾患診断市場を包括的にセグメントしています。また、タイプ別、アプリケーション別、プレイヤー別の製品に関する地域別市場規模も掲載しています。市場規模を推計する際には、COVID-19やロシア・ウクライナ戦争の影響も考慮しました。

市場をより深く理解するために、競合環境、主要な競合他社、それぞれの市場ランクなどのプロフィールを掲載しています。また、技術動向や新製品開発についても考察しています。
本レポートは、同市場における遺伝子疾患診断企業、新規参入企業、産業チェーン関連企業に対し、市場全体および企業別、製品タイプ別、用途別、地域別のサブセグメントにおける収益に関する情報を提供するものである。

主要企業および市場シェアの洞察
本セクションでは、読者は競合する主要企業について理解を深めることができます。本レポートでは、革新的なトレンドと開発、製品ポートフォリオの強化、M&A、コラボレーション、新製品イノベーション、地域的拡大など、これらの参加企業がプレゼンスを維持するために行った主要な成長戦略を調査しています。事業戦略とは別に、本調査には現在の開発状況や主要財務情報も含まれています。読者はまた、期間2017-2022の企業による世界収益に関連するデータへのアクセスを取得します。この包括的なレポートは、確かに更新を維持し、彼らのビジネスで効果的な意思決定を行うためにクライアントに役立つだろう。調査レポートでレビューされている著名なプレーヤーは以下の通りです。
アボット
パーキンエルマー
ロシュ・ダイアグノスティックス
バイオラッド
サーモフィッシャーサイエンティフィック
BGIグループ
ベリーゲノミクス
ダーアンジーン株式会社
イルミナ
キャピタルバイオテクノロジー

製品タイプ別インサイト
世界市場を遺伝子疾患診断薬のタイプ別に、2028年までの成長予測とともに紹介します。収益の見積もりは、遺伝子疾患診断薬が企業によって調達されるサプライチェーンにおける価格に基づいています。
本レポートでは、各セグメントを調査し、過去のデータを用いて市場規模を提示しています。また、そのセグメントが将来もたらすかもしれない成長機会についても触れています。この研究は、タイプ別、および歴史的期間(2017-2022)と予測期間(2023-2028)の収益データを授けるものである。
遺伝子疾患診断のタイプ別セグメント
出生前診断
単一遺伝子遺伝性疾患のスクリーニング
着床前遺伝子検査
その他

アプリケーションインサイト
本レポートでは、過去期間(2017-2022年)および予測期間(2023-2028年)におけるアプリケーション別の市場規模(収益データ)を掲載しています。
また、遺伝子疾患診断市場に影響を与える各分野の市場動向や消費者行動について概説し、これらが業界の将来にどのような示唆を与えるかについて解説しています。本レポートは、遺伝子疾患診断市場を牽引する関連市場および消費者動向の把握にお役立ていただけます。
遺伝子疾患診断の用途別セグメント
病院
医療ラボ
その他

地域別展望
本セクションでは、様々な地域と各地域で活動する主要企業に関する主要な洞察を提供します。特定の地域/国の成長を評価する際に、経済的、社会的、環境的、技術的、政治的な要因が考慮されています。読者はまた、2017年から2028年までの各地域および国の収益に手を触れることになります。
市場は、北米、ヨーロッパ、アジア太平洋、南米、中東&アフリカなど、様々な主要地域に区分されています。アメリカ、ドイツ、イギリス、イタリア、フランス、中国、日本、韓国、東南アジア、インドなどの主要国の詳細な分析は、地域セグメント内でカバーされる予定です。市場推定については、2021年を基準年としてデータを提供し、2022年の推定値と2028年の予測収益を提供する予定である。
北米
米国
カナダ
欧州
ドイツ
フランス
英国
イタリア
ロシア
北欧諸国
ベネルクス
その他の欧州地域
アジア太平洋地域
中国
日本
韓国
インド
東南アジア
オーストラリア
その他のアジア太平洋地域
中南米
メキシコ
ブラジル
アルゼンチン
ラテンアメリカのその他
中近東・アフリカ
トルコ
サウジアラビア
UAE
その他の中東・アフリカ

主要なドライバーと障壁
本レポートでは、読者が一般的な開発を理解するのに役立つように、影響の大きいレンダリング要因とドライバーを調査しています。さらに、このレポートには、プレイヤーの道を阻むブロックとして機能する可能性のある抑制と課題も含まれています。これは、ユーザーが気を配り、ビジネスに関連する情報に基づいた意思決定を行うために支援します。専門家はまた、今後のビジネスの展望に彼らの焦点を置いています。
COVID-19とロシア・ウクライナ戦争影響力分析
このセクションの読者は、遺伝子疾患診断市場のシナリオがパンデミック、ポストパンデミック、ロシア・ウクライナ戦争中に世界中でどのように変化したかを理解することができます。この研究は、需要、消費、輸送、消費者行動、サプライチェーン管理などの側面の変化を視野に入れて行われます。また、業界の専門家は、今後数年間でプレイヤーに機会を創出し、業界全体を安定させるのに役立つ主要因を強調しています。

本レポートを購入する理由
本レポートは、読者が潜在的な利益を高めるために、産業内の競争と競争環境に対する戦略を理解するのに役立ちます。また、世界の遺伝子疾患診断市場の競争環境に焦点を当て、主要企業の市場シェア、産業ランキング、競合他社のエコシステム、市場実績、新製品開発、経営状況、拡張、買収などを詳細に紹介し、読者が主要競合企業を特定し、市場の競争パターンを深く理解できるよう支援します。
本レポートは、利害関係者が遺伝子疾患診断の世界的な産業状況と動向を理解するのに役立ち、主要な市場促進要因、阻害要因、課題、機会に関する情報を提供します。
本レポートは、利害関係者が競合他社をより良く理解し、ビジネスにおける地位を強化するためのより多くの洞察を得るために役立ちます。競争環境のセクションでは、市場シェアと順位(金額)、競合のエコシステム、新製品開発、拡張、買収を含みます。
本レポートは、新規技術の統合、機能、市場の最新動向について常に更新しています。
本レポートは、利害関係者がCOVID-19とロシア・ウクライナ戦争が遺伝子疾患診断産業に及ぼす影響を理解するのに役立ちます。
本レポートは、利害関係者が世界的にどの地域をターゲットとすべきかを洞察するのに役立ちます。
本レポートは、利害関係者が遺伝子疾患診断の採用に関するエンドユーザーの認識について洞察することを支援します。
本レポートは、利害関係者が市場における主要プレイヤーを特定し、その貴重な貢献度を理解するのに役立ちます。


ページTOPに戻る


目次

1 Study Coverage
1.1 Genetic Disease Diagnostic Product Introduction
1.2 Market by Type
1.2.1 Global Genetic Disease Diagnostic Market Size Growth Rate by Type (2017 VS 2021 VS 2028)
1.2.2 Prenatal Diagnosis
1.2.3 Screening for Single Gene Genetic Disease
1.2.4 Preimplantation Genetic Testing
1.2.5 Others
1.3 Market by Application
1.3.1 Global Genetic Disease Diagnostic Market Size Growth Rate by Application (2017 VS 2021 VS 2028)
1.3.2 Hospital
1.3.3 Medical Laboratory
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Genetic Disease Diagnostic Market Size Estimates and Forecasts
2.2 Genetic Disease Diagnostic Market Size by Region: 2022 Versus 2028
2.2.1 Global Genetic Disease Diagnostic Revenue by Region: 2017-2022
2.2.2 Global Genetic Disease Diagnostic Revenue Forecast by Region (2023-2028)
2.2.3 Global Genetic Disease Diagnostic Revenue Market Share by Region (2017-2028)
3 Global Genetic Disease Diagnostic by Company
3.1 Global Genetic Disease Diagnostic Revenue by Company (2017-2022)
3.2 Global Genetic Disease Diagnostic Revenue Share by Company (2017-2022)
3.3 Competitive Landscape
3.3.1 Key Genetic Disease Diagnostic Companies around the World: Ranking by Revenue
3.3.2 Global Genetic Disease Diagnostic Market Concentration Ratio (CR5 and HHI) & (2017-2022)
3.3.3 Global Genetic Disease Diagnostic Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.4 Global Genetic Disease Diagnostic Companies Headquarters & Product Type
3.4.1 Genetic Disease Diagnostic Companies Headquarters
3.4.2 Global Genetic Disease Diagnostic Companies Product & Service
3.4.3 Date of International Companies Enter into Genetic Disease Diagnostic Market
3.5 Global Genetic Disease Diagnostic Mergers & Acquisitions, Expansion Plans
4 Company Profiles
4.1 Abbott
4.1.1 Abbott Corporation Information
4.1.2 Abbott Description, Business Overview
4.1.3 Abbott Genetic Disease Diagnostic Products Offered
4.1.4 Abbott Genetic Disease Diagnostic Revenue and Gross Margin (2017-2022)
4.1.5 Abbott Genetic Disease Diagnostic Revenue by Product in 2021
4.1.6 Abbott Genetic Disease Diagnostic Revenue by Application in 2021
4.1.7 Abbott Genetic Disease Diagnostic Revenue by Geographic Area in 2021
4.1.8 Abbott Recent Developments
4.2 PerkinElmer
4.2.1 PerkinElmer Corporation Information
4.2.2 PerkinElmer Description, Business Overview
4.2.3 PerkinElmer Genetic Disease Diagnostic Products Offered
4.2.4 PerkinElmer Genetic Disease Diagnostic Revenue and Gross Margin (2017-2022)
4.2.5 PerkinElmer Genetic Disease Diagnostic Revenue by Product in 2021
4.2.6 PerkinElmer Genetic Disease Diagnostic Revenue by Application in 2021
4.2.7 PerkinElmer Genetic Disease Diagnostic Revenue by Geographic Area in 2021
4.2.8 PerkinElmer Recent Developments
4.3 Roche Diagnostics
4.3.1 Roche Diagnostics Corporation Information
4.3.2 Roche Diagnostics Description, Business Overview
4.3.3 Roche Diagnostics Genetic Disease Diagnostic Products Offered
4.3.4 Roche Diagnostics Genetic Disease Diagnostic Revenue and Gross Margin (2017-2022)
4.3.5 Roche Diagnostics Genetic Disease Diagnostic Revenue by Product in 2021
4.3.6 Roche Diagnostics Genetic Disease Diagnostic Revenue by Application in 2021
4.3.7 Roche Diagnostics Genetic Disease Diagnostic Revenue by Geographic Area in 2021
4.3.8 Roche Diagnostics Recent Developments
4.4 Bio Rad
4.4.1 Bio Rad Corporation Information
4.4.2 Bio Rad Description, Business Overview
4.4.3 Bio Rad Genetic Disease Diagnostic Products Offered
4.4.4 Bio Rad Genetic Disease Diagnostic Revenue and Gross Margin (2017-2022)
4.4.5 Bio Rad Genetic Disease Diagnostic Revenue by Product in 2021
4.4.6 Bio Rad Genetic Disease Diagnostic Revenue by Application in 2021
4.4.7 Bio Rad Genetic Disease Diagnostic Revenue by Geographic Area in 2021
4.4.8 Bio Rad Recent Developments
4.5 Thermo Fisher Scientific
4.5.1 Thermo Fisher Scientific Corporation Information
4.5.2 Thermo Fisher Scientific Description, Business Overview
4.5.3 Thermo Fisher Scientific Genetic Disease Diagnostic Products Offered
4.5.4 Thermo Fisher Scientific Genetic Disease Diagnostic Revenue and Gross Margin (2017-2022)
4.5.5 Thermo Fisher Scientific Genetic Disease Diagnostic Revenue by Product in 2021
4.5.6 Thermo Fisher Scientific Genetic Disease Diagnostic Revenue by Application in 2021
4.5.7 Thermo Fisher Scientific Genetic Disease Diagnostic Revenue by Geographic Area in 2021
4.5.8 Thermo Fisher Scientific Recent Developments
4.6 BGI Group
4.6.1 BGI Group Corporation Information
4.6.2 BGI Group Description, Business Overview
4.6.3 BGI Group Genetic Disease Diagnostic Products Offered
4.6.4 BGI Group Genetic Disease Diagnostic Revenue and Gross Margin (2017-2022)
4.6.5 BGI Group Genetic Disease Diagnostic Revenue by Product in 2021
4.6.6 BGI Group Genetic Disease Diagnostic Revenue by Application in 2021
4.6.7 BGI Group Genetic Disease Diagnostic Revenue by Geographic Area in 2021
4.6.8 BGI Group Recent Development
4.7 Berry Genomics
4.7.1 Berry Genomics Corporation Information
4.7.2 Berry Genomics Description, Business Overview
4.7.3 Berry Genomics Genetic Disease Diagnostic Products Offered
4.7.4 Berry Genomics Genetic Disease Diagnostic Revenue and Gross Margin (2017-2022)
4.7.5 Berry Genomics Genetic Disease Diagnostic Revenue by Product in 2021
4.7.6 Berry Genomics Genetic Disease Diagnostic Revenue by Application in 2021
4.7.7 Berry Genomics Genetic Disease Diagnostic Revenue by Geographic Area in 2021
4.7.8 Berry Genomics Recent Development
4.8 Da An Gene Co., Ltd.
4.8.1 Da An Gene Co., Ltd. Corporation Information
4.8.2 Da An Gene Co., Ltd. Description, Business Overview
4.8.3 Da An Gene Co., Ltd. Genetic Disease Diagnostic Products Offered
4.8.4 Da An Gene Co., Ltd. Genetic Disease Diagnostic Revenue and Gross Margin (2017-2022)
4.8.5 Da An Gene Co., Ltd. Genetic Disease Diagnostic Revenue by Product in 2021
4.8.6 Da An Gene Co., Ltd. Genetic Disease Diagnostic Revenue by Application in 2021
4.8.7 Da An Gene Co., Ltd. Genetic Disease Diagnostic Revenue by Geographic Area in 2021
4.8.8 Da An Gene Co., Ltd. Recent Development
4.9 Illumina
4.9.1 Illumina Corporation Information
4.9.2 Illumina Description, Business Overview
4.9.3 Illumina Genetic Disease Diagnostic Products Offered
4.9.4 Illumina Genetic Disease Diagnostic Revenue and Gross Margin (2017-2022)
4.9.5 Illumina Genetic Disease Diagnostic Revenue by Product in 2021
4.9.6 Illumina Genetic Disease Diagnostic Revenue by Application in 2021
4.9.7 Illumina Genetic Disease Diagnostic Revenue by Geographic Area in 2021
4.9.8 Illumina Recent Development
4.10 CapitalBio Technology
4.10.1 CapitalBio Technology Corporation Information
4.10.2 CapitalBio Technology Description, Business Overview
4.10.3 CapitalBio Technology Genetic Disease Diagnostic Products Offered
4.10.4 CapitalBio Technology Genetic Disease Diagnostic Revenue and Gross Margin (2017-2022)
4.10.5 CapitalBio Technology Genetic Disease Diagnostic Revenue by Product in 2021
4.10.6 CapitalBio Technology Genetic Disease Diagnostic Revenue by Application in 2021
4.10.7 CapitalBio Technology Genetic Disease Diagnostic Revenue by Geographic Area in 2021
4.10.8 CapitalBio Technology Recent Development
5 Breakdown Data by Type
5.1 Global Genetic Disease Diagnostic Revenue by Type (2017-2022)
5.2 Global Genetic Disease Diagnostic Revenue Forecast by Type (2023-2028)
5.3 Genetic Disease Diagnostic Revenue Marke Share by Type (2017-2028)
6 Breakdown Data by Application
6.1 Global Genetic Disease Diagnostic Revenue by Application (2017-2022)
6.2 Global Genetic Disease Diagnostic Revenue Forecast by Application (2023-2028)
6.3 Genetic Disease Diagnostic Revenue Market Share by Application (2017-2028)
7 North America
7.1 North America Genetic Disease Diagnostic Market Size YoY Growth 2017-2028
7.2 North America Genetic Disease Diagnostic Market Facts & Figures by Country (2017-2028)
7.3 North America Genetic Disease Diagnostic Revenue by Type (2017-2022)
7.4 North America Genetic Disease Diagnostic Revenue by Application (2017-2022)
8 Asia-Pacific
8.1 Asia-Pacific Genetic Disease Diagnostic Market Size YoY Growth 2017-2028
8.2 Asia-Pacific Genetic Disease Diagnostic Market Facts & Figures by Region (2017-2028)
8.3 Asia-Pacific Genetic Disease Diagnostic Revenue by Type (2017-2022)
8.4 Asia-Pacific Genetic Disease Diagnostic Revenue by Application (2017-2022)
9 Europe
9.1 Europe Genetic Disease Diagnostic Market Size YoY Growth 2017-2028
9.2 Europe Genetic Disease Diagnostic Market Facts & Figures by Country (2017-2028)
9.3 Europe Genetic Disease Diagnostic Revenue by Type (2017-2022)
9.4 Europe Genetic Disease Diagnostic Revenue by Application (2017-2022)
10 Latin America
10.1 Latin America Genetic Disease Diagnostic Market Size YoY Growth 2017-2028
10.2 Latin America Genetic Disease Diagnostic Market Facts & Figures by Country (2017-2028)
10.3 Latin America Genetic Disease Diagnostic Revenue by Type (2017-2022)
10.4 Latin America Genetic Disease Diagnostic Revenue by Application (2017-2022)
11 Middle East and Africa
11.1 Middle East and Africa Genetic Disease Diagnostic Market Size YoY Growth 2017-2028
11.2 Middle East and Africa Genetic Disease Diagnostic Market Facts & Figures by Country (2017-2028)
11.3 Middle East and Africa Genetic Disease Diagnostic Revenue by Type (2017-2022)
11.4 Middle East and Africa Genetic Disease Diagnostic Revenue by Application (2017-2022)
12 Supply Chain and Sales Channel Analysis
12.1 Genetic Disease Diagnostic Supply Chain Analysis
12.2 Genetic Disease Diagnostic Key Raw Materials and Upstream Suppliers
12.3 Genetic Disease Diagnostic Clients Analysis
12.4 Genetic Disease Diagnostic Sales Channel and Sales Model Analysis
12.4.1 Genetic Disease Diagnostic Distribution Channel Analysis: Indirect Sales VS Direct Sales
12.4.2 Genetic Disease Diagnostic Distribution Channel Analysis: Online Sales VS Offline Sales
12.4.3 Genetic Disease Diagnostic Distributors
13 Market Dynamics
13.1 Genetic Disease Diagnostic Industry Trends
13.2 Genetic Disease Diagnostic Market Drivers
13.3 Genetic Disease Diagnostic Market Challenges
13.4 Genetic Disease Diagnostic Market Restraints
14 Research Findings and Conclusion
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

 

ページTOPに戻る


 

Summary

Hereditary diseases are those caused by changes in genetic material or controlled by disease-causing genes. Hereditary diseases refer to diseases that are determined wholly or partly by genetic factors, usually congenital or acquired. Be like congenital foolish model, much point to (toe), congenital deafness dumb, hemophilia, these hereditary disease decides to come on completely by genetic factor, and just after be born certain time comes on, want to pass a few years sometimes, more than ten years even ability after decades appears apparent symptom.

At present, China has adopted a variety of neonatal disease screening technologies for early diagnosis and treatment of children with genetic diseases without clinical symptoms, effectively reducing the disability rate and mortality rate of children, and greatly reducing the serious harm caused by birth defects to families and society. In recent years, with the rapid development of molecular biology and genomics, genetic testing technology has become the gold standard when it comes to most of the hereditary disease diagnosis, especially in the biochemical or enzymatic method can't make a diagnosis and test results under the condition of not clear, genetic testing is an important means of diagnosis, but in the field of neonatal hereditary disease screening, genetic testing technology is not yet ripe for applications, Gene screening for neonatal deafness has been reported in China.

Highlights
Considering the economic change due to COVID-19 and Russia-Ukraine War Influence, the global Genetic Disease Diagnostic market is projected to reach US$ million by 2028 from an estimated US$ million in 2022, at a CAGR of % during 2023 and 2028.
In China markets, the core manufacturers of genetic disease diagnostic includes BGI Group, Berry Genomics etc and the top 5 companies hold a share over 40%.

Report Scope
This report aims to provide a comprehensive presentation of the global market for Genetic Disease Diagnostic, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyse their position in the current marketplace, and make informed business decisions regarding Genetic Disease Diagnostic.

The Genetic Disease Diagnostic market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2021 as the base year, with history and forecast data for the period from 2017 to 2028. This report segments the global Genetic Disease Diagnostic market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Genetic Disease Diagnostic companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, product type, application, and regions.

Key Companies & Market Share Insights
In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue by companies for the period 2017-2022. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses. Some of the prominent players reviewed in the research report include:
Abbott
PerkinElmer
Roche Diagnostics
Bio Rad
Thermo Fisher Scientific
BGI Group
Berry Genomics
Da An Gene Co., Ltd.
Illumina
CapitalBio Technology

Product Type Insights
Global markets are presented by Genetic Disease Diagnostic type, along with growth forecasts through 2028. Estimates on revenue are based on the price in the supply chain at which the Genetic Disease Diagnostic are procured by the companies.
This report has studied every segment and provided the market size using historical data. They have also talked about the growth opportunities that the segment may pose in the future. This study bestows revenue data by type, and during the historical period (2017-2022) and forecast period (2023-2028).
Genetic Disease Diagnostic Segment by Type
Prenatal Diagnosis
Screening for Single Gene Genetic Disease
Preimplantation Genetic Testing
Others

Application Insights
This report has provided the market size (revenue data) by application, during the historical period (2017-2022) and forecast period (2023-2028).
This report also outlines the market trends of each segment and consumer behaviors impacting the Genetic Disease Diagnostic market and what implications these may have on the industry's future. This report can help to understand the relevant market and consumer trends that are driving the Genetic Disease Diagnostic market.
Genetic Disease Diagnostic Segment by Application
Hospital
Medical Laboratory
Others

Regional Outlook
This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the revenue of each region and country for the period 2017-2028.
The market has been segmented into various major geographies, including North America, Europe, Asia-Pacific, South America, Middle East & Africa. Detailed analysis of major countries such as the USA, Germany, the U.K., Italy, France, China, Japan, South Korea, Southeast Asia, and India will be covered within the regional segment. For market estimates, data are going to be provided for 2021 because of the base year, with estimates for 2022 and forecast revenue for 2028.
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia-Pacific
China
Japan
South Korea
India
Southeast Asia
Australia
Rest of Asia-Pacific
Latin America
Mexico
Brazil
Argentina
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of Middle East & Africa

Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
COVID-19 and Russia-Ukraine War Influence Analysis
The readers in the section will understand how the Genetic Disease Diagnostic market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.

Reasons to Buy This Report
This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Genetic Disease Diagnostic market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
This report will help stakeholders to understand the global industry status and trends of Genetic Disease Diagnostic and provides them with information on key market drivers, restraints, challenges, and opportunities.
This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.
This report stays updated with novel technology integration, features, and the latest developments in the market
This report helps stakeholders to understand the COVID-19 and Russia-Ukraine War Influence on the Genetic Disease Diagnostic industry.
This report helps stakeholders to gain insights into which regions to target globally.
This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Genetic Disease Diagnostic.
This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.



ページTOPに戻る


Table of Contents

1 Study Coverage
1.1 Genetic Disease Diagnostic Product Introduction
1.2 Market by Type
1.2.1 Global Genetic Disease Diagnostic Market Size Growth Rate by Type (2017 VS 2021 VS 2028)
1.2.2 Prenatal Diagnosis
1.2.3 Screening for Single Gene Genetic Disease
1.2.4 Preimplantation Genetic Testing
1.2.5 Others
1.3 Market by Application
1.3.1 Global Genetic Disease Diagnostic Market Size Growth Rate by Application (2017 VS 2021 VS 2028)
1.3.2 Hospital
1.3.3 Medical Laboratory
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Genetic Disease Diagnostic Market Size Estimates and Forecasts
2.2 Genetic Disease Diagnostic Market Size by Region: 2022 Versus 2028
2.2.1 Global Genetic Disease Diagnostic Revenue by Region: 2017-2022
2.2.2 Global Genetic Disease Diagnostic Revenue Forecast by Region (2023-2028)
2.2.3 Global Genetic Disease Diagnostic Revenue Market Share by Region (2017-2028)
3 Global Genetic Disease Diagnostic by Company
3.1 Global Genetic Disease Diagnostic Revenue by Company (2017-2022)
3.2 Global Genetic Disease Diagnostic Revenue Share by Company (2017-2022)
3.3 Competitive Landscape
3.3.1 Key Genetic Disease Diagnostic Companies around the World: Ranking by Revenue
3.3.2 Global Genetic Disease Diagnostic Market Concentration Ratio (CR5 and HHI) & (2017-2022)
3.3.3 Global Genetic Disease Diagnostic Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.4 Global Genetic Disease Diagnostic Companies Headquarters & Product Type
3.4.1 Genetic Disease Diagnostic Companies Headquarters
3.4.2 Global Genetic Disease Diagnostic Companies Product & Service
3.4.3 Date of International Companies Enter into Genetic Disease Diagnostic Market
3.5 Global Genetic Disease Diagnostic Mergers & Acquisitions, Expansion Plans
4 Company Profiles
4.1 Abbott
4.1.1 Abbott Corporation Information
4.1.2 Abbott Description, Business Overview
4.1.3 Abbott Genetic Disease Diagnostic Products Offered
4.1.4 Abbott Genetic Disease Diagnostic Revenue and Gross Margin (2017-2022)
4.1.5 Abbott Genetic Disease Diagnostic Revenue by Product in 2021
4.1.6 Abbott Genetic Disease Diagnostic Revenue by Application in 2021
4.1.7 Abbott Genetic Disease Diagnostic Revenue by Geographic Area in 2021
4.1.8 Abbott Recent Developments
4.2 PerkinElmer
4.2.1 PerkinElmer Corporation Information
4.2.2 PerkinElmer Description, Business Overview
4.2.3 PerkinElmer Genetic Disease Diagnostic Products Offered
4.2.4 PerkinElmer Genetic Disease Diagnostic Revenue and Gross Margin (2017-2022)
4.2.5 PerkinElmer Genetic Disease Diagnostic Revenue by Product in 2021
4.2.6 PerkinElmer Genetic Disease Diagnostic Revenue by Application in 2021
4.2.7 PerkinElmer Genetic Disease Diagnostic Revenue by Geographic Area in 2021
4.2.8 PerkinElmer Recent Developments
4.3 Roche Diagnostics
4.3.1 Roche Diagnostics Corporation Information
4.3.2 Roche Diagnostics Description, Business Overview
4.3.3 Roche Diagnostics Genetic Disease Diagnostic Products Offered
4.3.4 Roche Diagnostics Genetic Disease Diagnostic Revenue and Gross Margin (2017-2022)
4.3.5 Roche Diagnostics Genetic Disease Diagnostic Revenue by Product in 2021
4.3.6 Roche Diagnostics Genetic Disease Diagnostic Revenue by Application in 2021
4.3.7 Roche Diagnostics Genetic Disease Diagnostic Revenue by Geographic Area in 2021
4.3.8 Roche Diagnostics Recent Developments
4.4 Bio Rad
4.4.1 Bio Rad Corporation Information
4.4.2 Bio Rad Description, Business Overview
4.4.3 Bio Rad Genetic Disease Diagnostic Products Offered
4.4.4 Bio Rad Genetic Disease Diagnostic Revenue and Gross Margin (2017-2022)
4.4.5 Bio Rad Genetic Disease Diagnostic Revenue by Product in 2021
4.4.6 Bio Rad Genetic Disease Diagnostic Revenue by Application in 2021
4.4.7 Bio Rad Genetic Disease Diagnostic Revenue by Geographic Area in 2021
4.4.8 Bio Rad Recent Developments
4.5 Thermo Fisher Scientific
4.5.1 Thermo Fisher Scientific Corporation Information
4.5.2 Thermo Fisher Scientific Description, Business Overview
4.5.3 Thermo Fisher Scientific Genetic Disease Diagnostic Products Offered
4.5.4 Thermo Fisher Scientific Genetic Disease Diagnostic Revenue and Gross Margin (2017-2022)
4.5.5 Thermo Fisher Scientific Genetic Disease Diagnostic Revenue by Product in 2021
4.5.6 Thermo Fisher Scientific Genetic Disease Diagnostic Revenue by Application in 2021
4.5.7 Thermo Fisher Scientific Genetic Disease Diagnostic Revenue by Geographic Area in 2021
4.5.8 Thermo Fisher Scientific Recent Developments
4.6 BGI Group
4.6.1 BGI Group Corporation Information
4.6.2 BGI Group Description, Business Overview
4.6.3 BGI Group Genetic Disease Diagnostic Products Offered
4.6.4 BGI Group Genetic Disease Diagnostic Revenue and Gross Margin (2017-2022)
4.6.5 BGI Group Genetic Disease Diagnostic Revenue by Product in 2021
4.6.6 BGI Group Genetic Disease Diagnostic Revenue by Application in 2021
4.6.7 BGI Group Genetic Disease Diagnostic Revenue by Geographic Area in 2021
4.6.8 BGI Group Recent Development
4.7 Berry Genomics
4.7.1 Berry Genomics Corporation Information
4.7.2 Berry Genomics Description, Business Overview
4.7.3 Berry Genomics Genetic Disease Diagnostic Products Offered
4.7.4 Berry Genomics Genetic Disease Diagnostic Revenue and Gross Margin (2017-2022)
4.7.5 Berry Genomics Genetic Disease Diagnostic Revenue by Product in 2021
4.7.6 Berry Genomics Genetic Disease Diagnostic Revenue by Application in 2021
4.7.7 Berry Genomics Genetic Disease Diagnostic Revenue by Geographic Area in 2021
4.7.8 Berry Genomics Recent Development
4.8 Da An Gene Co., Ltd.
4.8.1 Da An Gene Co., Ltd. Corporation Information
4.8.2 Da An Gene Co., Ltd. Description, Business Overview
4.8.3 Da An Gene Co., Ltd. Genetic Disease Diagnostic Products Offered
4.8.4 Da An Gene Co., Ltd. Genetic Disease Diagnostic Revenue and Gross Margin (2017-2022)
4.8.5 Da An Gene Co., Ltd. Genetic Disease Diagnostic Revenue by Product in 2021
4.8.6 Da An Gene Co., Ltd. Genetic Disease Diagnostic Revenue by Application in 2021
4.8.7 Da An Gene Co., Ltd. Genetic Disease Diagnostic Revenue by Geographic Area in 2021
4.8.8 Da An Gene Co., Ltd. Recent Development
4.9 Illumina
4.9.1 Illumina Corporation Information
4.9.2 Illumina Description, Business Overview
4.9.3 Illumina Genetic Disease Diagnostic Products Offered
4.9.4 Illumina Genetic Disease Diagnostic Revenue and Gross Margin (2017-2022)
4.9.5 Illumina Genetic Disease Diagnostic Revenue by Product in 2021
4.9.6 Illumina Genetic Disease Diagnostic Revenue by Application in 2021
4.9.7 Illumina Genetic Disease Diagnostic Revenue by Geographic Area in 2021
4.9.8 Illumina Recent Development
4.10 CapitalBio Technology
4.10.1 CapitalBio Technology Corporation Information
4.10.2 CapitalBio Technology Description, Business Overview
4.10.3 CapitalBio Technology Genetic Disease Diagnostic Products Offered
4.10.4 CapitalBio Technology Genetic Disease Diagnostic Revenue and Gross Margin (2017-2022)
4.10.5 CapitalBio Technology Genetic Disease Diagnostic Revenue by Product in 2021
4.10.6 CapitalBio Technology Genetic Disease Diagnostic Revenue by Application in 2021
4.10.7 CapitalBio Technology Genetic Disease Diagnostic Revenue by Geographic Area in 2021
4.10.8 CapitalBio Technology Recent Development
5 Breakdown Data by Type
5.1 Global Genetic Disease Diagnostic Revenue by Type (2017-2022)
5.2 Global Genetic Disease Diagnostic Revenue Forecast by Type (2023-2028)
5.3 Genetic Disease Diagnostic Revenue Marke Share by Type (2017-2028)
6 Breakdown Data by Application
6.1 Global Genetic Disease Diagnostic Revenue by Application (2017-2022)
6.2 Global Genetic Disease Diagnostic Revenue Forecast by Application (2023-2028)
6.3 Genetic Disease Diagnostic Revenue Market Share by Application (2017-2028)
7 North America
7.1 North America Genetic Disease Diagnostic Market Size YoY Growth 2017-2028
7.2 North America Genetic Disease Diagnostic Market Facts & Figures by Country (2017-2028)
7.3 North America Genetic Disease Diagnostic Revenue by Type (2017-2022)
7.4 North America Genetic Disease Diagnostic Revenue by Application (2017-2022)
8 Asia-Pacific
8.1 Asia-Pacific Genetic Disease Diagnostic Market Size YoY Growth 2017-2028
8.2 Asia-Pacific Genetic Disease Diagnostic Market Facts & Figures by Region (2017-2028)
8.3 Asia-Pacific Genetic Disease Diagnostic Revenue by Type (2017-2022)
8.4 Asia-Pacific Genetic Disease Diagnostic Revenue by Application (2017-2022)
9 Europe
9.1 Europe Genetic Disease Diagnostic Market Size YoY Growth 2017-2028
9.2 Europe Genetic Disease Diagnostic Market Facts & Figures by Country (2017-2028)
9.3 Europe Genetic Disease Diagnostic Revenue by Type (2017-2022)
9.4 Europe Genetic Disease Diagnostic Revenue by Application (2017-2022)
10 Latin America
10.1 Latin America Genetic Disease Diagnostic Market Size YoY Growth 2017-2028
10.2 Latin America Genetic Disease Diagnostic Market Facts & Figures by Country (2017-2028)
10.3 Latin America Genetic Disease Diagnostic Revenue by Type (2017-2022)
10.4 Latin America Genetic Disease Diagnostic Revenue by Application (2017-2022)
11 Middle East and Africa
11.1 Middle East and Africa Genetic Disease Diagnostic Market Size YoY Growth 2017-2028
11.2 Middle East and Africa Genetic Disease Diagnostic Market Facts & Figures by Country (2017-2028)
11.3 Middle East and Africa Genetic Disease Diagnostic Revenue by Type (2017-2022)
11.4 Middle East and Africa Genetic Disease Diagnostic Revenue by Application (2017-2022)
12 Supply Chain and Sales Channel Analysis
12.1 Genetic Disease Diagnostic Supply Chain Analysis
12.2 Genetic Disease Diagnostic Key Raw Materials and Upstream Suppliers
12.3 Genetic Disease Diagnostic Clients Analysis
12.4 Genetic Disease Diagnostic Sales Channel and Sales Model Analysis
12.4.1 Genetic Disease Diagnostic Distribution Channel Analysis: Indirect Sales VS Direct Sales
12.4.2 Genetic Disease Diagnostic Distribution Channel Analysis: Online Sales VS Offline Sales
12.4.3 Genetic Disease Diagnostic Distributors
13 Market Dynamics
13.1 Genetic Disease Diagnostic Industry Trends
13.2 Genetic Disease Diagnostic Market Drivers
13.3 Genetic Disease Diagnostic Market Challenges
13.4 Genetic Disease Diagnostic Market Restraints
14 Research Findings and Conclusion
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

 

ページTOPに戻る

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

webからのご注文・お問合せはこちらのフォームから承ります

本レポートと同分野(通信回線)の最新刊レポート

本レポートと同じKEY WORD(diagnostic)の最新刊レポート


よくあるご質問


QYResearch社はどのような調査会社ですか?


QYリサーチ(QYResearch)は幅広い市場を対象に調査・レポート出版を行う、中国に本社をおく調査会社です。   QYResearchでは年間数百タイトルの調査レポートを出版しています。... もっと見る


調査レポートの納品までの日数はどの程度ですか?


在庫のあるものは速納となりますが、平均的には 3-4日と見て下さい。
但し、一部の調査レポートでは、発注を受けた段階で内容更新をして納品をする場合もあります。
発注をする前のお問合せをお願いします。


注文の手続きはどのようになっていますか?


1)お客様からの御問い合わせをいただきます。
2)見積書やサンプルの提示をいたします。
3)お客様指定、もしくは弊社の発注書をメール添付にて発送してください。
4)データリソース社からレポート発行元の調査会社へ納品手配します。
5) 調査会社からお客様へ納品されます。最近は、pdfにてのメール納品が大半です。


お支払方法の方法はどのようになっていますか?


納品と同時にデータリソース社よりお客様へ請求書(必要に応じて納品書も)を発送いたします。
お客様よりデータリソース社へ(通常は円払い)の御振り込みをお願いします。
請求書は、納品日の日付で発行しますので、翌月最終営業日までの当社指定口座への振込みをお願いします。振込み手数料は御社負担にてお願いします。
お客様の御支払い条件が60日以上の場合は御相談ください。
尚、初めてのお取引先や個人の場合、前払いをお願いすることもあります。ご了承のほど、お願いします。


データリソース社はどのような会社ですか?


当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
世界各国の「市場・技術・法規制などの」実情を調査・収集される時には、データリソース社にご相談ください。
お客様の御要望にあったデータや情報を抽出する為のレポート紹介や調査のアドバイスも致します。



詳細検索

このレポートへのお問合せ

03-3582-2531

電話お問合せもお気軽に

 

2024/11/14 10:27

156.77 円

166.04 円

201.95 円

ページTOPに戻る